Acetaminophen Pain Reliever Recalled for cGMP Deviations
Ultra Seal Corporation is recalling approximately 1.2 million packets of Maximum Strength Non Aspirin Pain Reliever/Fever Reducer due to current good manufacturing practice (cGMP) deviations. The affected product was distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The source classifies this as FDA Class II. The hazard is a manufacturing practice deviation without any reported illnesses, injuries, or deaths. The source text explicitly states the reason for recall is "cGMP deviations" with no indication of actual harm, making this a precautionary recall warranting a Moderate severity rating.
Plain-English summary
Ultra Seal Corporation is recalling approximately 1,236,000 packets of Maximum Strength Non Aspirin Pain Reliever/Fever Reducer (acetaminophen 500 mg) distributed nationwide in the United States. The affected product is the 2-tablet packet formulation manufactured for Advanced First Aid (Baltimore, MD) and American Safety & First Aid (Osceola, IN), with NDC 67060-210-68.
The recall was initiated due to current good manufacturing practice (cGMP) deviations identified at the manufacturing facility. The affected lots are AK9495 (expiration date 02/2022) and AK6413 (expiration date 05/2022).
This is a Class II recall initiated voluntarily by the firm on January 24, 2022. Consumers who have purchased this product should stop using it. The recall was terminated on October 16, 2023.
The recalled product
- Product
- Maximum Strength Non Aspirin Pain Reliever/Fever Reducer (acetaminophen 500 mg) 2 tablet packets, Mfg. for: Advanced First Aid, Baltimore MD 21237, American Safety & First Aid, Osceola, IN 46561, NDC 67060-210-68
- Manufacturer
- Ultra Seal Corporation
- Affected units
- 1,236,000
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: AK9495
- Exp. Date 02/2022
- AK9613
- Exp. Date 05/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 56 recalled by Ultra Seal Corporation under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 56 products in this recall →Related recalls
Same manufacturer · Ultra Seal Corporation
See all →- ModeratePEPTIME Energy Caffeine Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateExaprin Pain Reliever Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateCold Terminator decongestant recalled for cGMP deviations
FDA (Drugs) · 2022-02-09
- ModerateLite Remfresh Melatonin Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateExtra Strength Un-Aspirin Acetaminophen Packets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
Same hazard · manufacturing deviation
See all →- HighBaxter Recalls Vancomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateSynjardy XR Tablets Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2026-07-08
- ModerateDuloxetine delayed-release capsules recalled for N-nitroso impurity contamination
FDA (Drugs) · 2026-05-13
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
Similar recalls
- ModerateAdvance Formula Pain Reliever tablets recalled for failed stability specifications
FDA (Drugs) · 2021-11-03
- ModeratePhysicians CARE Extra Strength Pain Reliever recalled for CGMP deviations
FDA (Drugs) · 2022-01-26
- LowUltra Seal Recalls Pain Relief Tablets Due to Stability Failures
FDA (Drugs) · 2020-08-26
- ModerateXpect First Aid Extra Strength Pain Away tablets recalled for failed stability specifications
FDA (Drugs) · 2021-11-03
- ModerateExtra-Strength Unaspirin Caplet Recalled for CGMP Deviations
FDA (Drugs) · 2022-02-16
- LowUltra Seal Recalls Extra Strength Headache Relief Tablets for Stability Failures
FDA (Drugs) · 2020-08-26